DE69840928D1 - Nachweismethoden für reagenzien, die das "inhibitor-der-apoptose-protein" (iap) regulieren und dadurch auf die caspaseaktivität einwirken - Google Patents
Nachweismethoden für reagenzien, die das "inhibitor-der-apoptose-protein" (iap) regulieren und dadurch auf die caspaseaktivität einwirkenInfo
- Publication number
- DE69840928D1 DE69840928D1 DE69840928T DE69840928T DE69840928D1 DE 69840928 D1 DE69840928 D1 DE 69840928D1 DE 69840928 T DE69840928 T DE 69840928T DE 69840928 T DE69840928 T DE 69840928T DE 69840928 D1 DE69840928 D1 DE 69840928D1
- Authority
- DE
- Germany
- Prior art keywords
- iap
- reagents
- actuating
- regulating
- detection methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96466—Cysteine endopeptidases (3.4.22)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2510/00—Detection of programmed cell death, i.e. apoptosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86208797A | 1997-05-22 | 1997-05-22 | |
PCT/US1998/007357 WO1998053091A1 (en) | 1997-05-22 | 1998-04-10 | Screening assays for agents that alter inhibitor of apoptosis (iap) protein regulation of caspase activity |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69840928D1 true DE69840928D1 (de) | 2009-08-06 |
Family
ID=25337620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69840928T Expired - Lifetime DE69840928D1 (de) | 1997-05-22 | 1998-04-10 | Nachweismethoden für reagenzien, die das "inhibitor-der-apoptose-protein" (iap) regulieren und dadurch auf die caspaseaktivität einwirken |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0983376B1 (de) |
JP (2) | JP4068666B2 (de) |
AU (1) | AU760765B2 (de) |
CA (1) | CA2289972C (de) |
DE (1) | DE69840928D1 (de) |
WO (1) | WO1998053091A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6426411B1 (en) * | 1997-05-30 | 2002-07-30 | Dana-Farber Cancer Institute | PGC-1, a novel brown fat pparγ coactivator |
EP1151295A4 (de) * | 1999-02-01 | 2005-03-30 | Cytovia Inc | Verfahren zur identifizierung therapeutisch effektiver antineoplastischer substanzen mittels kultivierter zellen mit intakten zellmembranen und damit zusammenhängende produkte |
US6570069B1 (en) | 2000-02-10 | 2003-05-27 | Regents Of The University Of California | Nucleic acids encoding plant inhibitors of apoptosis and transgenic cells and plants expressing them |
US7172880B2 (en) | 2001-01-08 | 2007-02-06 | The Burnham Institute For Medical Research | Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them |
US6911426B2 (en) * | 2001-11-21 | 2005-06-28 | The Burnham Institute | Methods and compositions for derepression of IAP-inhibited caspase |
US20070049602A1 (en) * | 2005-05-26 | 2007-03-01 | The Board Of Trustees Of The University Of Illinois | Selective Apoptotic Induction in Cancer Cells Including Activation of Procaspase-3 |
WO2015109391A1 (en) | 2014-01-24 | 2015-07-30 | Children's Hospital Of Eastern Ontario Research Institute Inc. | Smc combination therapy for the treatment of cancer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5766848A (en) * | 1993-01-04 | 1998-06-16 | Synaptic Pharmaceutical Corporation | Methods for identifying compounds which specifically bind a human betaine/GABA transporter |
-
1998
- 1998-04-10 WO PCT/US1998/007357 patent/WO1998053091A1/en active IP Right Grant
- 1998-04-10 AU AU68988/98A patent/AU760765B2/en not_active Ceased
- 1998-04-10 EP EP98914689A patent/EP0983376B1/de not_active Expired - Lifetime
- 1998-04-10 DE DE69840928T patent/DE69840928D1/de not_active Expired - Lifetime
- 1998-04-10 CA CA2289972A patent/CA2289972C/en not_active Expired - Fee Related
- 1998-04-10 JP JP55035698A patent/JP4068666B2/ja not_active Expired - Fee Related
-
2006
- 2006-04-03 JP JP2006102591A patent/JP2006204308A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2006204308A (ja) | 2006-08-10 |
EP0983376B1 (de) | 2009-06-24 |
WO1998053091A1 (en) | 1998-11-26 |
EP0983376A1 (de) | 2000-03-08 |
EP0983376A4 (de) | 2004-10-20 |
AU760765B2 (en) | 2003-05-22 |
CA2289972A1 (en) | 1998-11-26 |
JP4068666B2 (ja) | 2008-03-26 |
JP2001510345A (ja) | 2001-07-31 |
CA2289972C (en) | 2011-06-07 |
AU6898898A (en) | 1998-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2721568B1 (fr) | Zone éclairable. | |
DE69819399D1 (de) | Rauchmelder und Steuersystem für die Anzeige | |
DE69822721D1 (de) | Vorrichtung für klinische Analysen | |
DE69623204D1 (de) | Modulares drahtloses Diagnose-, Test- und Informationssystem | |
DE69623312D1 (de) | Lager und Überwachungssystem für Lager | |
PT915846E (pt) | Fenilcetoenois 2-substituidos e 2,5-substituidos | |
NL1005115A1 (nl) | Kogeltjesmatrixsondesamenstel. | |
IT1277860B1 (it) | Dispositivo simmetrizzatore e procedimento per la sua progettazione. | |
DE69840928D1 (de) | Nachweismethoden für reagenzien, die das "inhibitor-der-apoptose-protein" (iap) regulieren und dadurch auf die caspaseaktivität einwirken | |
FI900451A0 (fi) | Kliniska tillaempningar. | |
DE69526203D1 (de) | Biologische zielgerichtete mittel | |
FI951029A (fi) | Mikroliuska-aaltoputkisiirtymä | |
TR199501562A2 (tr) | Tiyenopiridon'lar. | |
DE69832152D1 (de) | Lumineszenzmethode für das luciferin/luciferase-system und lumineszenzreagens | |
DE69733623D1 (de) | Snoopbus für zerteite transaktionen und arbitrierungsverfahren | |
DE69722221D1 (de) | Montagesystem für krankenhäuser | |
DE69832603D1 (de) | An plasmamebranen lokalisierte sialidasen und dafür kodierende dna | |
FR2716759B1 (fr) | Etage de formatage d'opérandes optimisé. | |
BR9509887A (pt) | Sistema controlado por computador | |
ES1027007Y (es) | Dispositivo facofragmentador de nucleo, desechable. | |
FR2721184B3 (fr) | Console. | |
SE9702117D0 (sv) | Blodanalyssystem | |
ES1037972Y (es) | "recipiente para analisis clinicos". | |
ITRM960313A0 (it) | Dispositivo di allarme anti-sonno per tele-video-spettatori e simili. | |
KR980002271U (ko) | 운전자의 피로 경보장치 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |